NSE · BSE · Real-time
High-value corporate events — new orders, fund raises, capacity expansions, and earning calls — analysed by AI the moment they hit the exchange.
Dr. Reddy's Laboratories has launched the first-to-market generic version of Bosulif (Bosutinib Tablets 400mg) in the United States. This strategic oncology launch, executed in collaboration with MSN Laboratories, grants the company 180 days of generic drug exclusivity for this specific dosage strength.
Real-time NSE & BSE event alerts, AI-summarized filings, and instant order-win signals — free for 15 days, no card required.
